BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 2263084)

  • 1. Octreotide acetate induces fasting small bowel motility in patients with dumping syndrome.
    Richards WO; Geer R; O'Dorisio TM; Robarts T; Parish KL; Rice D; Woltering G; Abumrad NN
    J Surg Res; 1990 Dec; 49(6):483-7. PubMed ID: 2263084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
    Geer RJ; Richards WO; O'Dorisio TM; Woltering EO; Williams S; Rice D; Abumrad NN
    Ann Surg; 1990 Dec; 212(6):678-87. PubMed ID: 2256759
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of nonendocrine gastrointestinal disorders with octreotide acetate.
    Woltering EA; O'Dorisio TM; Williams ST; Lebrado L; Fletcher WS
    Metabolism; 1990 Sep; 39(9 Suppl 2):176-9. PubMed ID: 1976212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of octreotide on gastric and small bowel motility in patients with gastroparesis.
    Edmunds MC; Chen JD; Soykan I; Lin Z; McCallum RW
    Aliment Pharmacol Ther; 1998 Feb; 12(2):167-74. PubMed ID: 9692691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Octreotide in dumping and short bowel syndromes.
    Farthing MJ
    Digestion; 1993; 54 Suppl 1():47-52. PubMed ID: 8359568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long acting somatostatin analogue in dumping syndrome.
    Tulassay Z; Tulassay T; Gupta R; Cierny G
    Br J Surg; 1989 Dec; 76(12):1294-5. PubMed ID: 2691013
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide improves early dumping syndrome potentially through incretins: a case report.
    Sato D; Morino K; Ohashi N; Ueda E; Ikeda K; Yamamoto H; Ugi S; Yamamoto H; Araki S; Maegawa H
    Endocr J; 2013; 60(7):847-53. PubMed ID: 23708181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Control of dumping symptoms by somatostatin analogue in patients after gastric surgery.
    Gray JL; Debas HT; Mulvihill SJ
    Arch Surg; 1991 Oct; 126(10):1231-5; discussion 1235-6. PubMed ID: 1929823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of octreotide on manometric variables in patients with neuropathic abnormalities of the small bowel.
    Bassotti G; Germani U; Calcara C; Spinozzi F; Roselli P; Morelli A
    Dig Dis Sci; 1997 Aug; 42(8):1634-9. PubMed ID: 9286228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The place of octreotide in the medical management of the dumping syndrome.
    Scarpignato C
    Digestion; 1996; 57 Suppl 1():114-8. PubMed ID: 8813487
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of the dumping syndrome with the somatostatin analogue SMS 201-995.
    Hopman WP; Wolberink RG; Lamers CB; Van Tongeren JH
    Ann Surg; 1988 Feb; 207(2):155-9. PubMed ID: 2893592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of octreotide on intestinal motility and bacterial overgrowth in scleroderma.
    Soudah HC; Hasler WL; Owyang C
    N Engl J Med; 1991 Nov; 325(21):1461-7. PubMed ID: 1944424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of octreotide on gastrointestinal pressure profiles in health and in functional and organic gastrointestinal disorders.
    Haruma K; Wiste JA; Camilleri M
    Gut; 1994 Aug; 35(8):1064-9. PubMed ID: 7926907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory effect of glucagon-like peptide-1 on small bowel motility. Fasting but not fed motility inhibited via nitric oxide independently of insulin and somatostatin.
    Tolessa T; Gutniak M; Holst JJ; Efendic S; Hellström PM
    J Clin Invest; 1998 Aug; 102(4):764-74. PubMed ID: 9710445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms by which octreotide ameliorates symptoms in the dumping syndrome.
    Hasler WL; Soudah HC; Owyang C
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1359-65. PubMed ID: 8667198
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome.
    Saslow SB; O'Brien MD; Camilleri M; von der Ohe M; Homburger HA; Klee GG; Pitot HC; Rubin J
    Am J Gastroenterol; 1997 Dec; 92(12):2250-6. PubMed ID: 9399764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of acute postoperative ileus with octreotide.
    Cullen JJ; Eagon JC; Dozois EJ; Kelly KA
    Am J Surg; 1993 Jan; 165(1):113-9; discussion 119-20. PubMed ID: 8418686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The action of octreotide in dumping syndrome].
    Hölscher AH
    Z Gastroenterol; 1990 Sep; 28 Suppl 2():45-9. PubMed ID: 2281705
    [No Abstract]   [Full Text] [Related]  

  • 19. Gut hormone profile and gastric emptying in the dumping syndrome. A hypothesis concerning the pathogenesis.
    Lawaetz O; Blackburn AM; Bloom SR; Aritas Y; Ralphs DN
    Scand J Gastroenterol; 1983 Jan; 18(1):73-80. PubMed ID: 6372067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Postgastrectomy dumping treated with octreotide (Sandostatin)].
    Møller TD; Carlsen CU
    Ugeskr Laeger; 1993 Jun; 155(23):1805-6. PubMed ID: 8317033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.